Serum Cytokeratin 19 Fragment Antigen 21-1 as a Diagnostic and Prognostic Biomarker for Thymic Carcinoma in Thymic Masses
CYFRA 21-1 emerges as a reliable diagnostic biomarker for distinguishing TC from other thymic masses. Moreover, it holds promise for prognosis evaluation and potentially for recurrence surveillance.
Authors
- Yingzhi Zheng
- Xinsheng Zhu (ORCID: https://orcid.org/0000-0002-5936-607X)
- Yue Liu (ORCID: https://orcid.org/0000-0003-4416-0973)
- Pengyu Fan (ORCID: https://orcid.org/0000-0002-7161-1824)
- P. Zhang
- Tieyuan Zhu
- Jianing Qiu
- Ziyun Shen
- Shuyu Ji
- Meixin Teng
Institutions
- Wuhan University (CN)
- Shanghai Pulmonary Hospital (CN)
- Renmin Hospital of Wuhan University (CN)
Publication Details
- Journal
- European Journal of Cardio-Thoracic Surgery
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1093/ejcts/ezag017
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00